Workflow
Ketogenic Diet
icon
Search documents
FDA Green Lights Avalon GloboCare's KetoAir Breathalyzer
Benzinga· 2026-01-21 14:35
Core Viewpoint - Avalon GloboCare Corp's stock is experiencing a decline without any specific news to justify the movement, despite the recent FDA registration renewal for its KetoAir device [1] Group 1: Product Overview - The KetoAir device is a handheld breathalyzer that measures breath acetone concentration (BrAce), a biomarker linked to fat metabolism and nutritional ketosis [2] - Utilizing nano-sensor technology, KetoAir offers real-time, non-invasive insights into metabolic states through breath analysis, targeting individuals on ketogenic diets for various purposes [2] - The device is compatible with both iOS and Android smartphones, with applications available on major app stores [3] Group 2: Market Strategy - Avalon GloboCare plans to launch the KetoAir device in both B2B and B2C markets, enhancing marketing and distribution through its subsidiary, Avalon Quantum AI, LLC [3] - Marketing efforts for the device are set to begin in the second quarter of 2026, which is viewed as a significant milestone for the company [4] Group 3: Stock Performance - The stock is currently trading 31.1% below its 20-day simple moving average (SMA) and 55.5% below its 100-day SMA, indicating strong bearish momentum [5] - Over the past year, shares have decreased by 70.51%, and the stock is closer to its 52-week lows than highs [5] - As of the latest publication, shares were down 23.64% at $0.84, marking a new 52-week low [7]
Avalon GloboCare to Launch Online Sales of KetoAir Breathalyzer in the United Kingdom
Globenewswire· 2025-08-28 13:00
Core Viewpoint - Avalon GloboCare Corp. is launching the KetoAir™ breathalyzer device in the UK, expanding its market presence following its U.S. launch, targeting individuals on ketogenic diets for health management [1][3]. Product Overview - KetoAir™ is a handheld breathalyzer that measures breath acetone concentration (BrAce), indicating fat metabolism and ketosis, and is registered as a Class I medical device with the U.S. FDA [2][4]. - The device is designed for users pursuing ketogenic diets for weight loss, athletic performance, or therapeutic purposes, utilizing advanced nano-sensor technology for real-time metabolic insights [2][3]. Market Strategy - The launch in the UK is seen as a strategic move to capitalize on the growing adoption of ketogenic and low-carb diets, positioning KetoAir™ as a tool to help individuals achieve their health and wellness goals [3]. - The product will be available for purchase starting September 1, 2025, through the dedicated website [1][3]. Company Background - Avalon GloboCare Corp. focuses on developing precision diagnostic consumer products and advancing intellectual property in cellular therapy, with plans to explore additional diagnostic uses for the breathalyzer technology [4].
Avalon GloboCare Enters into Distribution Agreement with Saga Health for KetoAir Targeting First Responders
Globenewswire· 2025-07-28 13:00
Core Viewpoint - Avalon GloboCare Corp. has announced a wholesale distribution agreement with Saga Health Corporation for the KetoAir™ breathalyzer device, aimed at first responders as part of Saga's Holistic Health Reset Program [1][3]. Company Overview - Avalon GloboCare Corp. (NASDAQ: ALBT) specializes in precision diagnostic consumer products and cellular therapy intellectual property [5]. - The company is currently marketing the KetoAir™ breathalyzer, which is registered as a Class I medical device with the U.S. FDA [5]. - Avalon also focuses on advancing its intellectual property portfolio through existing patent applications and operates commercial real estate [5]. Product Details - The KetoAir™ breathalyzer is designed for ketogenic health management, measuring breath acetone concentration (BrAce) to indicate fat metabolism and ketosis [2]. - It is intended for users on ketogenic diets for weight loss, athletic performance, or therapeutic purposes, utilizing nano-sensor technology for real-time insights [2]. - The device is compatible with both Apple and Android devices and is available on the Apple App Store and Google Play Store [2]. Partnership Significance - The agreement with Saga Health is seen as a milestone for accelerating the commercial expansion of the KetoAir™ device [3]. - The collaboration aims to meet the growing demand for personalized, real-time monitoring of BrAce among those pursuing ketogenic lifestyles [3]. - Saga Health's Holistic Health Reset Program provides personalized nutritional guidance and tools like the KetoAir™ breathalyzer to improve participants' health [6].